Gregg Blevins Selected Research

Disease Progression

4/2009

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregg Blevins Research Topics

Disease

14	Multiple Sclerosis 03/2018 - 06/2003
4	Relapsing-Remitting Multiple Sclerosis 07/2021 - 07/2010
3	Demyelinating Diseases (Demyelinating Disease) 03/2018 - 08/2016
2	Lymphopenia (Lymphocytopenia) 07/2021 - 03/2018
2	Ischemic Stroke 01/2021 - 01/2005
2	Stroke (Strokes) 01/2021 - 01/2005
1	HIV Infections (HIV Infection) 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2020
1	Dizziness (Lightheadedness) 01/2017
1	Exanthema (Rash) 01/2017
1	Muscular Diseases (Myopathy) 08/2016
1	Autoimmune Diseases (Autoimmune Disease) 08/2016
1	Rheumatoid Arthritis 08/2016
1	Heart Failure 08/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2016
1	Neoplasms (Cancer) 01/2013
1	Cardiotoxicity 01/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Myocarditis (Carditis) 01/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2009
1	Inflammation (Inflammations) 04/2009
1	Disease Progression 04/2009

Drug/Important Bio-Agent (IBA)

7	IronIBA 08/2019 - 04/2012
2	Dimethyl FumarateIBA 07/2021 - 03/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016 - 01/2013
2	InterferonsIBA 01/2012 - 07/2010
2	Daclizumab (Zenapax)FDA Link 04/2009 - 06/2004
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Inosine Triphosphate (ITP)IBA 01/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2020
1	BerylliumIBA 01/2020
1	CalciumIBA 03/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 03/2018
1	Protons (Proton)IBA 04/2017
1	Minocycline (Cyclops)FDA LinkGeneric 01/2017
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2016
1	Methotrexate (Mexate)FDA LinkGeneric 08/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016
1	fludarabineIBA 02/2016
1	Rituximab (Mabthera)FDA Link 02/2016
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	Coloring Agents (Dyes)IBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2013
1	Human Serum Albumin FDA LinkGeneric 01/2012
1	Bovine Serum AlbuminIBA 01/2012
1	Interferon beta-1a FDA Link 07/2010
1	RolipramIBA 10/2009
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2009
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2009
1	OligonucleotidesIBA 01/2005
1	Messenger RNA (mRNA)IBA 01/2005
1	Interferon-betaIBA 06/2004
1	Monoclonal AntibodiesIBA 06/2004

Therapy/Procedure

4	Therapeutics 07/2021 - 06/2004
1	Thrombectomy 01/2021
1	Immunotherapy 06/2003